13F 机构持仓

Pfizer Inc

New York NY · SEC CIK 0000078003

2026Q22026Q1 更早 9 个季度 🔒
$2.39亿2026Q1 申报市值
18持仓数
96.2%前十大占比 · 第一大 24.1%
1 / 1新建仓 / 清仓
申报市值走势$1.70亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

ORIC 24.1%
ALLO 20.9%
ARVN 14.6%
CELC 13.1%
ZURA 7.1%
WVE 5.0%
PYXIS ONCOLOGY 3.9%
CARIBOU BIOSCI 3.5%
SPERO THERAPEU 2.3%
BHVN 1.8%

2026Q1 买入最多 按季末市值估算

AGMB 新建仓+$81.38万

2026Q1 卖出最多 按季末市值估算

ORIC 减仓-$718.71万
CELC 减仓-$569.90万
QTTB 减仓-$127.72万
AN2 THERAPEUTICS 清仓-$81.54万
ZURA 减仓-$77.75万

2026Q1 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▼占比股数变动股数变动估算买卖额操作
ORIC ORIC PHARMACEUTICALS INC $5,765.16万24.14%4,780,401 -595,943-11.1% -$718.71万 减仓
ALLO ALLOGENE THERAPEUTICS INC $4,979.24万20.85%22,032,040 00.0% — 不变
ARVN ARVINAS INC $3,492.39万14.63%3,457,815 00.0% — 不变
CELC CELCUITY INC $3,134.50万13.13%295,652 -53,754-15.4% -$569.90万 减仓
ZURA ZURA BIO LTD $1,683.48万7.05%2,838,913 -131,109-4.4% -$77.75万 减仓
WVE WAVE LIFE SCIENCES LTD $1,193.44万5.00%1,875,000 00.0% — 不变
— PYXIS ONCOLOGY INC $921.29万3.86%7,032,770 00.0% — 不变
— CARIBOU BIOSCIENCES INC $834.90万3.50%4,690,431 00.0% — 不变
— SPERO THERAPEUTICS INC $550.43万2.31%2,362,348 00.0% — 不变
BHVN BIOHAVEN LTD $423.22万1.77%505,645 00.0% — 不变
— CARDIFF ONCOLOGY INC $373.79万1.57%2,411,575 00.0% — 不变
ZNTL ZENTALIS PHARMACEUTICALS INC $200.31万0.84%953,834 00.0% — 不变
— NEXTCURE INC $153.51万0.64%153,354 -4,292-2.7% -$4.30万 减仓
AGMB AGOMAB THERAPEUTICS NV $81.38万0.34%75,000 75,000— $81.38万 新建仓
QTTB Q32 BIO INC $73.67万0.31%101,618 -176,159-63.4% -$127.72万 减仓
— BOLT BIOTHERAPEUTICS INC $13.71万0.06%31,305 00.0% — 不变
DNA GINKGO BIOWORKS HOLDINGS INC $1.74万0.01%2,928 00.0% — 不变
— SENSEONICS HLDGS INC $1.42万0.01%2,171 00.0% — 不变
— AN2 THERAPEUTICS INC $00.00%0 -715,295-100.0% -$81.54万 清仓